Keith W. Pfeil - 02 Feb 2023 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
SVP, Chief Financial Officer
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Issuer symbol
GMED
Transactions as of
02 Feb 2023
Net transactions value
-$759,984
Form type
4
Filing time
06 Feb 2023, 15:52:27 UTC
Previous filing
27 Feb 2023
Next filing
19 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Options Exercise $703,392 +14,167 $49.65 14,167 02 Feb 2023 Direct
transaction GMED Class A Common Stock Options Exercise $799,050 +15,000 +106% $53.27 29,167 02 Feb 2023 Direct
transaction GMED Class A Common Stock Sale $2,262,426 -29,167 -100% $77.57 0 02 Feb 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -14,167 -71% $0.000000 5,833 02 Feb 2023 Class A Common Stock 14,167 $49.65 Direct F3
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -15,000 -62% $0.000000 9,167 02 Feb 2023 Class A Common Stock 15,000 $53.27 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.50 to $77.885, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3 These options were granted on September 3, 2019 and are fully vested.
F4 These options were granted on January 22, 2020 and are fully vested.